-
Beneficial microbiome and diet interplay in early-onset colorectal cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-09 Zhengyuan Zhou,Linda Kleis,Ana Depetris-Chauvin,Stefanie Jaskulski,Victoria Damerell,Karin B Michels,Biljana Gigic,Ute Nöthlings,Gianni Panagiotou
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Although the risk of developing CRC increases with age, approximately 10% of newly diagnosed cases occur in individuals under the age of 50. Significant changes in dietary habits in young adults since industrialization create a favorable microenvironment for colorectal
-
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-09 Rosalie Matico,Karolien Grauwen,Dhruv Chauhan,Xiaodi Yu,Irini Abdiaj,Suraj Adhikary,Ine Adriaensen,Garcia Molina Aranzazu,Jesus Alcázar,Michela Bassi,Ellen Brisse,Santiago Cañellas,Shubhra Chaudhuri,Francisca Delgado,Alejandro Diéguez-Vázquez,Marc Du Jardin,Victoria Eastham,Michael Finley,Tom Jacobs,Ken Keustermans,Robert Kuhn,Josep Llaveria,Jos Leenaerts,Maria Lourdes Linares,Maria Luz Martín,Rosa
The NLRP3 inflammasome plays a pivotal role in host defense and drives inflammation against microbial threats, crystals, and danger-associated molecular patterns (DAMPs). Dysregulation of NLRP3 activity is associated with various human diseases, making it an attractive therapeutic target. Patients with NLRP3 mutations suffer from Cryopyrin-Associated Periodic Syndrome (CAPS) emphasizing the clinical
-
A novel anti-epileptogenesis strategy of temporal lobe epilepsy based on nitric oxide donor. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-09 Xian-Hui Zhu,Ya-Ping Zhou,Qiao Zhang,Ming-Yi Zhu,Xiao-Wei Song,Jun Li,Jiang Chen,Yun Shi,Kang-Jian Sun,Yong-Jie Zhang,Jing Zhang,Tian Xia,Bao-Sheng Huang,Fan Meng,Qi-Gang Zhou
The molecular mechanism underlying the role of hippocampal hilar interneuron degeneration in temporal lobe epilepsy (TLE) remains unclear. Especially, very few studies have focused on the role of neuronal nitric oxide synthase (nNOS, encoded by Nos1) containing hilar interneurons in TLE. In the present study, Nos1 conditional knockout mice were constructed, and we found that selective deletion of Nos1
-
The inflammasome adaptor protein ASC promotes amyloid deposition in cryopyrin-associated periodic syndromes. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-05 Cristina Alarcón-Vila,Laura Hurtado-Navarro,Sandra V Mateo,Alejandro Peñín-Franch,Carlos M Martínez,Cristina Molina-López,María C Baños,Ana I Gómez,Javier Gómez-Román,Alberto Baroja-Mazo,Juan I Arostegui,Natalia Palmou-Fontana,Juan J Martínez-García,Pablo Pelegrin
-
Targeting to BMP9 to restrain flare-up of fibrodysplasia ossificans progressiva. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-03 Qiwen Li,Quan Yuan
-
BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-β signaling. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-12-03 Chengzhu Zhao,Yoshiko Inada,Souta Motoike,Daisuke Kamiya,Kyosuke Hino,Makoto Ikeya
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder presenting with progressive heterotopic ossification (HO) in soft tissues. Early-stage FOP is characterized by recurrent episodes of painful tissue swelling (flare-ups), with numerous proliferation-activated mesenchymal stromal cells (MSCs) subsequently causing HO. However, the mechanisms underlying flare-up progression remain unclear
-
Bi-allelic variants in WDR47 cause a complex neurodevelopmental syndrome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-28 Efil Bayam,Peggy Tilly,Stephan C Collins,José Rivera Alvarez,Meghna Kannan,Lucile Tonneau,Elena Brivio,Bruno Rinaldi,Romain Lecat,Noémie Schwaller,Ludovica Cotellessa,Sateesh Maddirevula,Fabiola Monteiro,Carlos M Guardia,João Paulo Kitajima,Fernando Kok,Mitsuhiro Kato,Ahlam A A Hamed,Mustafa A Salih,Saeed Al Tala,Mais O Hashem,Hiroko Tada,Hirotomo Saitsu,Mariano Stabile,Paolo Giacobini,Sylvie Friant
Brain development requires the coordinated growth of structures and cues that are essential for forming neural circuits and cognitive functions. The corpus callosum, the largest interhemispheric connection, is formed by the axons of callosal projection neurons through a series of tightly regulated cellular events, including neuronal specification, migration, axon extension and branching. Defects in
-
The role of PM2.5 exposure in lung cancer: mechanisms, genetic factors, and clinical implications. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-22 Chi-Yuan Chen,Kuo-Yen Huang,Chin-Chuan Chen,Ya-Hsuan Chang,Hsin-Jung Li,Tong-Hong Wang,Pan-Chyr Yang
Lung cancer is one of the most critical global health threats, as the second most common cancer and leading cause of cancer deaths globally. While smoking is the primary risk factor, an increasing number of cases occur in nonsmokers, with lung cancer in nonsmokers (LCNS) now recognized as the fifth leading cause of cancer mortality worldwide. Recent evidence identifies air pollution, particularly fine
-
Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-20 Laura Cassina,Alessandra Boletta
-
PDE12 mediated pruning of the poly-A tail of mitochondrial DNA-encoded tRNAs is essential for survival. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-20 Chenxiao Yu,Marco Tigano,Erin L Seifert
-
Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-20 Yongzhan Sun,Quan Zou,Huizheng Yu,Xiaoping Yi,Xudan Dou,Yu Yang,Zhiheng Liu,Hong Yang,Junya Jia,Yupeng Chen,Shao-Kai Sun,Lirong Zhang
Melanin-like nanoparticles (MNPs) have recently emerged as valuable agents in antioxidant therapy due to their excellent biocompatibility and potent capacity to scavenge various reactive oxygen species (ROS). However, previous studies have mainly focused on acute ROS-related diseases, leaving a knowledge gap regarding their potential in chronic conditions. Furthermore, apart from their well-established
-
Pathogenic PDE12 variants impair mitochondrial RNA processing causing neonatal mitochondrial disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-20 Lindsey Van Haute,Petra Páleníková,Jia Xin Tang,Pavel A Nash,Mariella T Simon,Angela Pyle,Monika Oláhová,Christopher A Powell,Pedro Rebelo-Guiomar,Alexander Stover,Michael Champion,Charulata Deshpande,Emma L Baple,Karen L Stals,Sian Ellard,Olivia Anselem,Clémence Molac,Giulia Petrilli,Laurence Loeuillet,Sarah Grotto,Tania Attie-Bitach,Jose E Abdenur,Robert W Taylor,Michal Minczuk
Pathogenic variants in either the mitochondrial or nuclear genomes are associated with a diverse group of human disorders characterized by impaired mitochondrial function. Within this group, an increasing number of families have been identified, where Mendelian genetic disorders implicate defective mitochondrial RNA biology. The PDE12 gene encodes the poly(A)-specific exoribonuclease, involved in the
-
Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-14 Ze-Rong Cai,Wen Wang,Di Chen,Hao-Jie Chen,Yan Hu,Xiao-Jing Luo,Yi-Ting Wang,Yi-Qian Pan,Hai-Yu Mo,Shu-Yu Luo,Kun Liao,Zhao-Lei Zeng,Shan-Shan Li,Xin-Yuan Guan,Xin-Juan Fan,Hai-Long Piao,Rui-Hua Xu,Huai-Qiang Ju
Early detection is warranted to improve prognosis of gastric cancer (GC) but remains challenging. Liquid biopsy combined with machine learning will provide new insights into diagnostic strategies of GC. Lipid metabolism reprogramming plays a crucial role in the initiation and development of tumors. Here, we integrated the lipidomics data of three cohorts (n = 944) to develop the lipid metabolic landscape
-
APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-11 Pranav Preman,Daan Moechars,Emre Fertan,Leen Wolfs,Lutgarde Serneels,Disha Shah,Jochen Lamote,Suresh Poovathingal,An Snellinx,Renzo Mancuso,Sriram Balusu,David Klenerman,Amaia M Arranz,Mark Fiers,Bart De Strooper
The major genetic risk factor for Alzheimer's disease (AD), APOE4, accelerates beta-amyloid (Aβ) plaque formation, but whether this is caused by APOE expressed in microglia or astrocytes is debated. We express here the human APOE isoforms in astrocytes in an Apoe-deficient AD mouse model. This is not only sufficient to restore the amyloid plaque pathology but also induces the characteristic transcriptional
-
JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-09 Karoline Strobl,Jörg Klufa,Regina Jin,Lena Artner-Gent,Dana Krauß,Philipp Novoszel,Johanna Strobl,Georg Stary,Igor Vujic,Johannes Griss,Martin Holcmann,Matthias Farlik,Bernhard Homey,Maria Sibilia,Thomas Bauer
The hair follicle stem cell niche is an immune-privileged microenvironment, characterized by reduced antigen presentation, thus shielding against permanent immune-mediated tissue damage. In this study, we demonstrated the protective role of hair follicle-specific epidermal growth factor receptor (EGFR) against scarring hair follicle destruction. Mechanistically, disruption of EGFR signaling generated
-
Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-09 Joseph S Durgin,Sunny Y Wong
-
Rett syndrome: interferon-γ to the rescue? EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-04 Richard R Meehan,Sari Pennings
-
Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-30 Jing Chen,Michal Sobecki,Ewelina Krzywinska,Kevin Thierry,Mélissa Masmoudi,Shunmugam Nagarajan,Zheng Fan,Jingyi He,Irina Ferapontova,Eric Nelius,Frauke Seehusen,Dagmar Gotthardt,Norihiko Takeda,Lukas Sommer,Veronika Sexl,Christian Münz,David DeNardo,Ana Hennino,Christian Stockmann
A hallmark feature of pancreatic ductal adenocarcinoma (PDAC) is massive intratumoral fibrosis, designated as desmoplasia. Desmoplasia is characterized by the expansion of cancer-associated fibroblasts (CAFs) and a massive increase in extracellular matrix (ECM). During fibrogenesis, distinct genes become reactivated specifically in fibroblasts, e.g., the disintegrin metalloprotease, ADAM12. Previous
-
Aberrant fragmentomic features of circulating cell-free mitochondrial DNA as novel biomarkers for multi-cancer detection. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-30 Yang Liu,Fan Peng,Siyuan Wang,Huanmin Jiao,Miao Dang,Kaixiang Zhou,Wenjie Guo,Shanshan Guo,Huanqin Zhang,Wenjie Song,Jinliang Xing
Fragmentomic features of circulating cell free mitochondrial DNA (ccf-mtDNA) including fragmentation profile, 5' end base preference and motif diversity are poorly understood. Here, we generated ccf-mtDNA sequencing data of 1607 plasma samples using capture-based next generation sequencing. We firstly found that fragmentomic features of ccf-mtDNA were remarkably different from those of circulating
-
Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-30 Morgane Fournier,Joaquim Javary,Vincent Roh,Nadine Fournier,Freddy Radtke
Cancer cell plasticity contributes significantly to the failure of chemo- and targeted therapies in triple-negative breast cancer (TNBC). Molecular mechanisms of therapy-induced tumor cell plasticity and associated resistance are largely unknown. Using a genome-wide CRISPR-Cas9 screen, we investigated escape mechanisms of NOTCH-driven TNBC treated with a gamma-secretase inhibitor (GSI) and identified
-
Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-29 Huiting Wang,Ziting Zhao,Mingming Song,Wenxiang Zhang,Chang Liu,Siyu Chen
Di-(2-ethylhexyl) phthalate (DEHP), an environmental pollutant, has been widely detected in both environmental and clinical samples, representing a serious threat to the homeostasis of the endocrine system. The accumulation of DEHP is notably pronounced in the liver and can lead to liver damage. The lack of effective high-throughput screening system retards the discovery of such drugs that can specifically
-
Liver DE(HP)toxification: luteolin as "phthalates-cleaner" to protect from environmental pollution. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-29 Federica Cappelli,Alessandro Mengozzi
-
Sepsis-induced changes in pyruvate metabolism: insights and potential therapeutic approaches. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-28 Louise Nuyttens,Jolien Vandewalle,Claude Libert
Sepsis is a heterogeneous syndrome resulting from a dysregulated host response to infection. It is considered as a global major health priority. Sepsis is characterized by significant metabolic perturbations, leading to increased circulating metabolites such as lactate. In mammals, pyruvate is the primary substrate for lactate production. It plays a critical role in metabolism by linking glycolysis
-
Ependymal cell lineage reprogramming as a potential therapeutic intervention for hydrocephalus. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-28 Konstantina Kaplani,Maria-Eleni Lalioti,Styliani Vassalou,Georgia Lokka,Evangelia Parlapani,Georgios Kritikos,Zoi Lygerou,Stavros Taraviras
Hydrocephalus is a common neurological condition, characterized by the excessive accumulation of cerebrospinal fluid in the cerebral ventricles. Primary treatments for hydrocephalus mainly involve neurosurgical cerebrospinal fluid diversion, which hold high morbidity and failure rates, highlighting the necessity for the discovery of novel therapeutic approaches. Although the pathophysiology of hydrocephalus
-
Epigenetic regulation by polycomb repressive complex 1 promotes cerebral cavernous malformations. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-14 Van-Cuong Pham,Claudia Jasmin Rödel,Mariaelena Valentino,Matteo Malinverno,Alessio Paolini,Juliane Münch,Candice Pasquier,Favour C Onyeogaziri,Bojana Lazovic,Romuald Girard,Janne Koskimäki,Melina Hußmann,Benjamin Keith,Daniel Jachimowicz,Franziska Kohl,Astrid Hagelkruys,Josef M Penninger,Stefan Schulte-Merker,Issam A Awad,Ryan Hicks,Peetra U Magnusson,Eva Faurobert,Massimiliano Pagani,Salim Abdelilah-Seyfried
Cerebral cavernous malformations (CCMs) are anomalies of the cerebral vasculature. Loss of the CCM proteins CCM1/KRIT1, CCM2, or CCM3/PDCD10 trigger a MAPK-Krüppel-like factor 2 (KLF2) signaling cascade, which induces a pathophysiological pattern of gene expression. The downstream target genes that are activated by KLF2 are mostly unknown. Here we show that Chromobox Protein Homolog 7 (CBX7), component
-
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-14 Alessandro Esposito,Tommaso Seri,Martina Breccia,Marzia Indrigo,Giuseppina De Rocco,Francesca Nuzzolillo,Vanna Denti,Francesca Pappacena,Gaia Tartaglione,Simone Serrao,Giuseppe Paglia,Luca Murru,Stefano de Pretis,Jean-Michel Cioni,Nicoletta Landsberger,Fabrizia Claudia Guarnieri,Michela Palmieri
Loss-of-function mutations in MECP2 are associated to Rett syndrome (RTT), a severe neurodevelopmental disease. Mainly working as a transcriptional regulator, MeCP2 absence leads to gene expression perturbations resulting in deficits of synaptic function and neuronal activity. In addition, RTT patients and mouse models suffer from a complex metabolic syndrome, suggesting that related cellular pathways
-
Targeting USP11 regulation by a novel lithium-organic coordination compound improves neuropathologies and cognitive functions in Alzheimer transgenic mice. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-11 Yi Guo,Chuanbin Cai,Bingjie Zhang,Bo Tan,Qinmin Tang,Zhifeng Lei,Xiaolan Qi,Jiang Chen,Xiaojiang Zheng,Dan Zi,Song Li,Jun Tan
Alzheimer's Disease (AD), as the most common neurodegenerative disease worldwide, severely impairs patients' cognitive functions. Although its exact etiology remains unclear, the abnormal aggregations of misfolded β-amyloid peptide and tau protein are considered pivotal in its pathological progression. Recent studies identify ubiquitin-specific protease 11 (USP11) as the key regulator of tau deubiquitination
-
Troubling bonds: lipid unsaturation promotes selenium dependency and sensitivity to ferroptosis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-07 Ancély Ferreira Dos Santos,José Pedro Friedmann-Angeli
-
Jag1 insufficiency alters liver fibrosis via T cell and hepatocyte differentiation defects. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-02 Jan Mašek,Iva Filipovic,Noémi Van Hul,Lenka Belicová,Markéta Jiroušková,Daniel V Oliveira,Anna Maria Frontino,Simona Hankeova,Jingyan He,Fabio Turetti,Afshan Iqbal,Igor Červenka,Lenka Sarnová,Elisabeth Verboven,Tomáš Brabec,Niklas K Björkström,Martin Gregor,Jan Dobeš,Emma R Andersson
Fibrosis contributes to tissue repair, but excessive fibrosis disrupts organ function. Alagille syndrome (ALGS, caused by mutations in JAGGED1) results in liver disease and characteristic fibrosis. Here, we show that Jag1Ndr/Ndr mice, a model for ALGS, recapitulate ALGS-like fibrosis. Single-cell RNA-seq and multi-color flow cytometry of the liver revealed immature hepatocytes and paradoxically low
-
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-02 Jessica P Wiseman,Joseph M Scarrott,João Alves-Cruzeiro,Afshin Saffari,Cedric Böger,Evangelia Karyka,Emily Dawes,Alexandra K Davies,Paolo M Marchi,Emily Graves,Fiona Fernandes,Zih-Liang Yang,Ian Coldicott,Jennifer Hirst,Christopher P Webster,J Robin Highley,Neil Hackett,Adrienn Angyal,Thushan de Silva,Adrian Higginbottom,Pamela J Shaw,Laura Ferraiuolo,Darius Ebrahimi-Fakhari,Mimoun Azzouz
Spastic paraplegia 47 (SPG47) is a neurological disorder caused by mutations in the adaptor protein complex 4 β1 subunit (AP4B1) gene leading to AP-4 complex deficiency. SPG47 is characterised by progressive spastic paraplegia, global developmental delay, intellectual disability and epilepsy. Gene therapy aimed at restoring functional AP4B1 protein levels is a rational therapeutic strategy to ameliorate
-
A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-10-02 Aude Boulay,Emmanuel Quevarec,Isabelle Malet,Giuseppe Nicastro,Célia Chamontin,Suzon Perrin,Corinne Henriquet,Martine Pugnière,Valérie Courgnaud,Mickaël Blaise,Anne-Geneviève Marcelin,Ian A Taylor,Laurent Chaloin,Nathalie J Arhel
HIV-1 capsids cross nuclear pore complexes (NPCs) by engaging with the nuclear import machinery. To identify compounds that inhibit HIV-1 nuclear import, we screened drugs in silico on a three-dimensional model of a CA hexamer bound by Transportin-1 (TRN-1). Among hits, compound H27 inhibited HIV-1 with a low micromolar IC50. Unlike other CA-targeting compounds, H27 did not alter CA assembly or disassembly
-
Mutation in the mitochondrial chaperone TRAP1 leads to autism with more severe symptoms in males. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-27 Małgorzata Rydzanicz,Bozena Kuzniewska,Marta Magnowska,Tomasz Wójtowicz,Aleksandra Stawikowska,Anna Hojka,Ewa Borsuk,Ksenia Meyza,Olga Gewartowska,Jakub Gruchota,Jacek Miłek,Patrycja Wardaszka,Izabela Chojnicka,Ludwika Kondrakiewicz,Dorota Dymkowska,Alicja Puścian,Ewelina Knapska,Andrzej Dziembowski,Rafał Płoski,Magdalena Dziembowska
There is increasing evidence of mitochondrial dysfunction in autism spectrum disorders (ASD), but the causal relationships are unclear. In an ASD patient whose identical twin was unaffected, we identified a postzygotic mosaic mutation p.Q639* in the TRAP1 gene, which encodes a mitochondrial chaperone of the HSP90 family. Additional screening of 176 unrelated ASD probands revealed an identical TRAP1
-
Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-11-01 Hung-Chang Chen,Nico Mueller,Katherine Stott,Chrysa Kapeni,Eilidh Rivers,Carolin M Sauer,Flavio Beke,Stephen J Walsh,Nicola Ashman,Louise O'Brien,Amir Rafati Fard,Arman Ghodsinia,Changtai Li,Fadwa Joud,Olivier Giger,Inti Zlobec,Ioana Olan,Sarah J Aitken,Matthew Hoare,Richard Mair,Eva Serrao,James D Brenton,Alicia Garcia-Gimenez,Simon E Richardson,Brian Huntly,David R Spring,Mikkel-Ole Skjoedt,Karsten
-
RIG-I is an intracellular checkpoint that limits CD8+ T-cell antitumour immunity. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-25 Xiaobing Duan,Jiali Hu,Yuncong Zhang,Xiaoguang Zhao,Mingqi Yang,Taoping Sun,Siya Liu,Xin Chen,Juan Feng,Wenting Li,Ze Yang,Yitian Zhang,Xiaowen Lin,Dingjie Liu,Ya Meng,Guang Yang,Qiuping Lin,Guihai Zhang,Haihong Lei,Zhengsheng Yi,Yanyan Liu,Xiaobing Liang,Yujuan Wu,Wenqing Diao,Zesong Li,Haihai Liang,Meixiao Zhan,Hong-Wei Sun,Xian-Yang Li,Ligong Lu
Retinoic acid-inducible gene I (RIG-I) is a pattern recognition receptor involved in innate immunity, but its role in adaptive immunity, specifically in the context of CD8+ T-cell antitumour immunity, remains unclear. Here, we demonstrate that RIG-I is upregulated in tumour-infiltrating CD8+ T cells, where it functions as an intracellular checkpoint to negatively regulate CD8+ T-cell function and limit
-
Infection length and host environment influence on Plasmodium falciparum dry season reservoir. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-16 Carolina M Andrade,Manuela Carrasquilla,Usama Dabbas,Jessica Briggs,Hannah van Dijk,Nikolay Sergeev,Awa Sissoko,Moussa Niangaly,Christina Ntalla,Emily LaVerriere,Jeff Skinner,Klara Golob,Jeremy Richter,Hamidou Cisse,Shanping Li,Jason A Hendry,Muhammad Asghar,Didier Doumtabe,Anna Farnert,Thomas Ruppert,Daniel E Neafsey,Kassoum Kayentao,Safiatou Doumbo,Aissata Ongoiba,Peter D Crompton,Boubacar Traore
Persistence of malaria parasites in asymptomatic hosts is crucial in areas of seasonally-interrupted transmission, where P. falciparum bridges wet seasons months apart. During the dry season, infected erythrocytes exhibit extended circulation with reduced cytoadherence, increasing the risk of splenic clearance of infected cells and hindering parasitaemia increase. However, what determines parasite
-
Whole-sporozoite malaria vaccines: where we are, where we are going. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-16 Diana Moita,Miguel Prudêncio
The malaria vaccination landscape has seen significant advancements with the recent endorsement of RTS,S/AS01 and R21/Matrix-M vaccines, which target the pre-erythrocytic stages of Plasmodium falciparum (Pf) infection. However, several challenges remain to be addressed, including the incomplete protection afforded by these vaccines, their dependence on a single Pf antigen, and the fact that they were
-
7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-16 Kishan Kumar Gaur,Tejeswara Rao Asuru,Mitul Srivastava,Nitu Singh,Nikil Purushotham,Boja Poojary,Bhabatosh Das,Sankar Bhattacharyya,Shailendra Asthana,Prasenjit Guchhait
There are a limited number of effective vaccines against dengue virus (DENV) and significant efforts are being made to develop potent anti-virals. Previously, we described that platelet-chemokine CXCL4 negatively regulates interferon (IFN)-α/β synthesis and promotes DENV2 replication. An antagonist to CXCR3 (CXCL4 receptor) reversed it and inhibited viral replication. In a concurrent search, we identified
-
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Chiara Pozzato,Gonçalo Outeiro-Pinho,Mirco Galiè,Giorgio Ramadori,Georgia Konstantinidou
Mutated KRAS serves as the oncogenic driver in 30% of non-small cell lung cancers (NSCLCs) and is associated with metastatic and therapy-resistant tumors. Focal Adhesion Kinase (FAK) acts as a mediator in sustaining KRAS-driven lung tumors, and although FAK inhibitors are currently undergoing clinical development, clinical data indicated that their efficacy in producing long-term anti-tumor responses
-
CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Robert Greensmith,Isadora T Lape,Cristian V Riella,Alexander J Schubert,Jakob J Metzger,Anand S Dighe,Xiao Tan,Bernhard Hemmer,Josefine Rau,Sarah Wendlinger,Nora Diederich,Anja Schütz,Leonardo V Riella,Michael M Kaminski
Detecting genetic variants enables risk factor identification, disease screening, and initiation of preventative therapeutics. However, current methods, relying on hybridization or sequencing, are unsuitable for point-of-care settings. In contrast, CRISPR-based-diagnostics offer high sensitivity and specificity for point-of-care applications. While these methods have predominantly been used for pathogen
-
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn's disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Xuehua Li,Shixian Hu,Xiaodi Shen,Ruonan Zhang,Caiguang Liu,Lin Xiao,Jinjiang Lin,Li Huang,Weitao He,Xinyue Wang,Lili Huang,Qingzhu Zheng,Luyao Wu,Canhui Sun,Zhenpeng Peng,Minhu Chen,Ziping Li,Rui Feng,Yijun Zhu,Yangdi Wang,Zhoulei Li,Ren Mao,Shi-Ting Feng
Intestinal fibrosis is the primary cause of disability in patients with Crohn's disease (CD), yet effective therapeutic strategies are currently lacking. Here, we report a multiomics analysis of gut microbiota and fecal/blood metabolites of 278 CD patients and 28 healthy controls, identifying characteristic alterations in gut microbiota (e.g., Lachnospiraceae, Ruminococcaceae, Muribaculaceae, Saccharimonadales)
-
An intrinsic mechanism of metabolic tuning promotes cardiac resilience to stress. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-13 Matteo Sorge,Giulia Savoré,Andrea Gallo,Davide Acquarone,Mauro Sbroggiò,Silvia Velasco,Federica Zamporlini,Saveria Femminò,Enrico Moiso,Giampaolo Morciano,Elisa Balmas,Andrea Raimondi,Gabrielle Nattenberg,Rachele Stefania,Carlo Tacchetti,Angela Maria Rizzo,Paola Corsetto,Alessandra Ghigo,Emilia Turco,Fiorella Altruda,Lorenzo Silengo,Paolo Pinton,Nadia Raffaelli,Nathan J Sniadecki,Claudia Penna,Pasquale
Defining the molecular mechanisms underlying cardiac resilience is crucial to find effective approaches to protect the heart. A physiologic level of ROS is produced in the heart by fatty acid oxidation, but stressful events can boost ROS and cause mitochondrial dysfunction and cardiac functional impairment. Melusin is a muscle specific chaperone required for myocardial compensatory remodeling during
-
Trained immunity of intestinal tuft cells during infancy enhances host defense against enteroviral infections in mice. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-11 Deyan Chen,Jing Wu,Fang Zhang,Ruining Lyu,Qiao You,Yajie Qian,Yurong Cai,Xiaoyan Tian,Hongji Tao,Yating He,Waqas Nawaz,Zhiwei Wu
Innate immune cells have been acknowledged as trainable in recent years. While intestinal tuft cells are recognized for their crucial roles in the host defense against intestinal pathogens, there remains uncertainty regarding their trainability. Enterovirus 71 (EV71), a prevalent enterovirus that primarily infects children but rarely infects adults. At present, there is a significant expansion of intestinal
-
A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-11 Céline Van Dender,Steven Timmermans,Ville Paakinaho,Tineke Vanderhaeghen,Jolien Vandewalle,Maarten Claes,Bruno Garcia,Bart Roman,Jan De Waele,Siska Croubels,Karolien De Bosscher,Philip Meuleman,Antoine Herpain,Jorma J Palvimo,Claude Libert
In sepsis, limited food intake and increased energy expenditure induce a starvation response, which is compromised by a quick decline in the expression of hepatic PPARα, a transcription factor essential in intracellular catabolism of free fatty acids. The mechanism upstream of this PPARα downregulation is unknown. We found that sepsis causes a progressive hepatic loss-of-function of HNF4α, which has
-
The influence of AHR on immune and tissue biology. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-06 Brigitta Stockinger,Oscar E Diaz,Emma Wincent
The aryl hydrocarbon receptor is a ligand dependent transcription factor which functions as an environmental sensor. Originally discovered as the sensor for man made pollutants such as 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) it has recently gained prominence as an important mediator for environmental triggers via the diet or microbiota which influences many physiological functions in different cell
-
Next generation of "magic bullets", solutions from the microbial pangenome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-06 Vega Masignani,Rino Rappuoli,Mariagrazia Pizza
-
Can we manipulate the ovary's own metabolism to protect it from chemotherapy-induced damage? EMBO Mol. Med. (IF 9.0) Pub Date : 2024-09-03 Adomas Liugaila,Agnes Stefansdottir,Norah Spears
-
The gray boundaries of aberrant shortening of the cellular timekeepers' edges. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-28 Guillermo Guenechea,Nestor W Meza
-
The evolving genetic landscape of telomere biology disorder dyskeratosis congenita. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-28 Hemanth Tummala,Amanda J Walne,Mohsin Badat,Manthan Patel,Abigail M Walne,Jenna Alnajar,Chi Ching Chow,Ibtehal Albursan,Jennifer M Frost,David Ballard,Sally Killick,Peter Szitányi,Anne M Kelly,Manoj Raghavan,Corrina Powell,Reinier Raymakers,Tony Todd,Elpis Mantadakis,Sophia Polychronopoulou,Nikolas Pontikos,Tianyi Liao,Pradeep Madapura,Upal Hossain,Tom Vulliamy,Inderjeet Dokal
Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome, caused by genetic mutations that principally affect telomere biology. Approximately 35% of cases remain uncharacterised at the genetic level. To explore the genetic landscape, we conducted genetic studies on a large collection of clinically diagnosed cases of DC as well as cases exhibiting features resembling DC, referred
-
Human breast tissue engineering in health and disease. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-23 Maj-Britt Buchholz,Demi I Scheerman,Riccardo Levato,Ellen J Wehrens,Anne C Rios
The human mammary gland represents a highly organized and dynamic tissue, uniquely characterized by postnatal developmental cycles. During pregnancy and lactation, it undergoes extensive hormone-stimulated architectural remodeling, culminating in the formation of specialized structures for milk production to nourish offspring. Moreover, it carries significant health implications, due to the high prevalence
-
Novel immunotherapeutics against LGR5 to target multiple cancer types. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Hung-Chang Chen,Nico Mueller,Katherine Stott,Chrysa Kapeni,Eilidh Rivers,Carolin M Sauer,Flavio Beke,Stephen J Walsh,Nicola Ashman,Louise O'Brien,Amir Rafati Fard,Arman Ghodsinia,Changtai Li,Fadwa Joud,Olivier Giger,Inti Zlobec,Ioana Olan,Sarah J Aitken,Matthew Hoare,Richard Mair,Eva Serrao,James D Brenton,Alicia Garcia-Gimenez,Simon E Richardson,Brian Huntly,David R Spring,Mikkel-Ole Skjoedt,Karsten
We have developed and validated a highly specific, versatile antibody to the extracellular domain of human LGR5 (α-LGR5). α-LGR5 detects LGR5 overexpression in >90% of colorectal cancer (CRC), hepatocellular carcinoma (HCC) and pre-B-ALL tumour cells and was used to generate an Antibody-Drug Conjugate (α-LGR5-ADC), Bispecific T-cell Engager (α-LGR5-BiTE) and Chimeric Antigen Receptor (α-LGR5-CAR).
-
Fertility protection during chemotherapy treatment by boosting the NAD(P)+ metabolome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Wing-Hong Jonathan Ho,Maria B Marinova,Dave R Listijono,Michael J Bertoldo,Dulama Richani,Lynn-Jee Kim,Amelia Brown,Angelique H Riepsamen,Safaa Cabot,Emily R Frost,Sonia Bustamante,Ling Zhong,Kaisa Selesniemi,Derek Wong,Romanthi Madawala,Maria Marchante,Dale M Goss,Catherine Li,Toshiyuki Araki,David J Livingston,Nigel Turner,David A Sinclair,Kirsty A Walters,Hayden A Homer,Robert B Gilchrist,Lindsay
Chemotherapy induced ovarian failure and infertility is an important concern in female cancer patients of reproductive age or younger, and non-invasive, pharmacological approaches to maintain ovarian function are urgently needed. Given the role of reduced nicotinamide adenine dinucleotide phosphate (NADPH) as an essential cofactor for drug detoxification, we sought to test whether boosting the NAD(P)+
-
Restoration of defective oxidative phosphorylation to a subset of neurons prevents mitochondrial encephalopathy. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-21 Brittni R Walker,Lise-Michelle Theard,Milena Pinto,Monica Rodriguez-Silva,Sandra R Bacman,Carlos T Moraes
Oxidative Phosphorylation (OXPHOS) defects can cause severe encephalopathies and no effective treatment exists for these disorders. To assess the ability of gene replacement to prevent disease progression, we subjected two different CNS-deficient mouse models (Ndufs3/complex I or Cox10/complex IV conditional knockouts) to gene therapy. We used retro-orbitally injected AAV-PHP.eB to deliver the missing
-
Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-20 Yue Wang,Hanbing Wang,Tao Shi,Xueru Song,Xin Zhang,Yue Zhang,Xuan Wang,Keying Che,Yuting Luo,Lixia Yu,Baorui Liu,Jia Wei
The CLDN18-ARHGAP fusion gene is an oncogenic driver newly discovered in gastric cancer. It was detected in 9% (8/87) of gastric cancer patients in our center. An immunogenic peptide specifically targeting CLDN18-ARHGAP fusion gene was generated to induce neoantigen-reactive T cells, which was proved to have specific and robust anti-tumor capacity both in in vitro coculture models and in vivo xenograft
-
An enhanced intracellular delivery platform based on a distant diphtheria toxin homolog that evades pre-existing antitoxin antibodies. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-19 Shivneet K Gill,Seiji N Sugiman-Marangos,Greg L Beilhartz,Elizabeth Mei,Mikko Taipale,Roman A Melnyk
Targeted intracellular delivery of therapeutic proteins remains a significant unmet challenge in biotechnology. A promising approach is to leverage the intrinsic capabilities of bacterial toxins like diphtheria toxin (DT) to deliver a potent cytotoxic enzyme into cells with an associated membrane translocation moiety. Despite showing promising clinical efficacy, widespread deployment of DT-based therapeutics
-
Histidine-rich glycoprotein modulates neutrophils and thrombolysis-associated hemorrhagic transformation. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-15 Wei Jiang,Yuexin Zhao,Rongrong Liu,Bohao Zhang,Yuhan Xie,Bin Gao,Kaibin Shi,Ming Zou,Dongmei Jia,Jiayue Ding,Xiaowei Hu,Yanli Duan,Ranran Han,DeRen Huang,Luc Van Kaer,Fu-Dong Shi
Intravenous thrombolysis using recombinant tissue plasminogen activator (tPA) remains the primary treatment for patients with acute ischemic stroke (AIS). However, the mechanism of tPA-related hemorrhagic transformation (HT) remains poorly understood. Elevation of histidine-rich glycoprotein (HRG) expression was detected by nano-liquid chromatography tandem mass spectrometry at 1 h following tPA infusion
-
Comprehensive molecular characterization of collecting duct carcinoma for therapeutic vulnerability. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-09 Peiyong Guan,Jianfeng Chen,Chengqiang Mo,Tomoya Fukawa,Chao Zhang,Xiuyu Cai,Mei Li,Jing Han Hong,Jason Yongsheng Chan,Cedric Chuan Young Ng,Jing Yi Lee,Suet Far Wong,Wei Liu,Xian Zeng,Peili Wang,Rong Xiao,Vikneswari Rajasegaran,Swe Swe Myint,Abner Ming Sun Lim,Joe Poh Sheng Yeong,Puay Hoon Tan,Choon Kiat Ong,Tao Xu,Yiqing Du,Fan Bai,Xin Yao,Bin Tean Teh,Jing Tan
Collecting duct carcinoma (CDC) is an aggressive rare subtype of kidney cancer with unmet clinical needs. Little is known about its underlying molecular alterations and etiology, primarily due to its rarity, and lack of preclinical models. This study aims to comprehensively characterize molecular alterations in CDC and identify its therapeutic vulnerabilities. Through whole-exome and transcriptome
-
Inhibition of GSK3α,β rescues cognitive phenotypes in a preclinical mouse model of CTNNB1 syndrome. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-05 Jonathan M Alexander,Leeanne Vazquez-Ramirez,Crystal Lin,Pantelis Antonoudiou,Jamie Maguire,Florence Wagner,Michele H Jacob
CTNNB1 syndrome is a rare monogenetic disorder caused by CTNNB1 de novo pathogenic heterozygous loss-of-function variants that result in cognitive and motor disabilities. Treatment is currently lacking; our study addresses this critical need. CTNNB1 encodes β-catenin which is essential for normal brain function via its dual roles in cadherin-based synaptic adhesion complexes and canonical Wnt signal
-
The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-08-05 Jinhai Deng,Teng Pan,Dan Wang,Yourae Hong,Zaoqu Liu,Xingang Zhou,Zhengwen An,Lifeng Li,Giovanna Alfano,Gang Li,Luigi Dolcetti,Rachel Evans,Jose M Vicencio,Petra Vlckova,Yue Chen,James Monypenny,Camila Araujo De Carvalho Gomes,Gregory Weitsman,Kenrick Ng,Caitlin McCarthy,Xiaoping Yang,Zedong Hu,Joanna C Porter,Christopher J Tape,Mingzhu Yin,Fengxiang Wei,Manuel Rodriguez-Justo,Jin Zhang,Sabine Tejpar
Chemotherapy, the standard of care treatment for cancer patients with advanced disease, has been increasingly recognized to activate host immune responses to produce durable outcomes. Here, in colorectal adenocarcinoma (CRC) we identify oxaliplatin-induced Thioredoxin-Interacting Protein (TXNIP), a MondoA-dependent tumor suppressor gene, as a negative regulator of Growth/Differentiation Factor 15 (GDF15)
-
Therapeutic targeting ERRγ suppresses metastasis via extracellular matrix remodeling in small cell lung cancer. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-31 Hong Wang,Huizi Sun,Jie Huang,Zhenhua Zhang,Guodi Cai,Chaofan Wang,Kai Xiao,Xiaofeng Xiong,Jian Zhang,Peiqing Liu,Xiaoyun Lu,Weineng Feng,Junjian Wang
Small-cell lung cancer (SCLC) is the most aggressive and lethal type of lung cancer, characterized by limited treatment options, early and frequent metastasis. However, the determinants of metastasis in SCLC are poorly defined. Here, we show that estrogen-related receptor gamma (ERRγ) is overexpressed in metastatic SCLC tumors, and is positively associated with SCLC progression. ERRγ functions as an
-
The RhoB p.S73F mutation leads to cerebral palsy through dysregulation of lipid homeostasis. EMBO Mol. Med. (IF 9.0) Pub Date : 2024-07-30 Xinyu Wu,Ruonan Liu,Zhongtian Zhang,Jie Yang,Xin Liu,Liqiang Jiang,Mengmeng Fang,Shoutang Wang,Liangxue Lai,Yuning Song,Zhanjun Li
Cerebral palsy (CP) is a prevalent neurological disorder that imposes a significant burden on children, families, and society worldwide. Recently, the RhoB p.S73F mutation was identified as a de novo mutation associated with CP. However, the mechanism by which the RhoB p.S73F mutation causes CP is currently unclear. In this study, rabbit models were generated to mimic the human RhoB p.S73F mutation